KiraGen Bio
Founded 2023 · 6 employees on LinkedIn · 3 known investors
Find your way into KiraGen Bio
894 people in our graph share verified history with the KiraGen Bio team — schools, employers, funds. One of them is your warm intro.
Anthony Philippakisunlockedknows Ryan Murray, PhD · together at Brigham and Women's Hospital (overlapped)
×3knows the team · via Beam Therapeutics
×3knows the team · via Harvard Business School
knows the team · via Northeastern University
knows the team · via Bluebird Bio
×2knows the team · via Massachusetts General Hospital
KiraGen Bio develops cell-therapy approaches aimed at treating brain cancers, with a focus on therapies designed to remain functional under suppressive tumor conditions. Its work targets pediatric brain cancers such as diffuse midline glioma (DMG) and DIPG.
Founders & leadership
KiraGen Bio was founded in 2023 by Aaron Edwards and Ryan Murray, PhD.
AE
Aaron EdwardsinCo-Founder/CEOAaron Edwards holds an MS/MBA in Biotechnology from Harvard Business School and previously held leadership positions at Beam Therapeutics and bluebird bio, with over a decade of experience in gene editing, cell therapy, immunotherapy, and mRNA therapeutics. He founded KiraGen Bio to develop gene-edited, donor-derived cell therapies designed to overcome suppression in the tumor microenvironment.
RM
Ryan Murray, PhDinCo-Founder & Chief Scientific OfficerRyan Murray holds a PhD and founded KiraGen Bio, which develops gene-edited cell therapies designed to resist tumor microenvironment suppression through multiple targeted genetic modifications.
Investors · 3
In the news
Frequently asked questions
- What does KiraGen Bio do?
- KiraGen Bio develops cell-therapy approaches aimed at treating brain cancers, with a focus on therapies designed to remain functional under suppressive tumor conditions. Its work targets pediatric brain cancers such as diffuse midline glioma (DMG) and DIPG.
- Who founded KiraGen Bio?
- KiraGen Bio was founded by Aaron Edwards, Ryan Murray, PhD in 2023.
- Who are KiraGen Bio's investors?
- KiraGen Bio's investors include 2048 Ventures, Fifty Years, ZAKA VC.